AstraZeneca’s immunotherapy Imfinzi helped people in the early stages of a type of lung cancer live 23 months longer than those who received just chemoradiotherapy, according to clinical trial data released Sunday. The finding should help the U.K.-based pharmaceutical company expand the drug’s use in the disease. Researchers in the study, called Adriatic, used Imfinzi […]
Tag: AstraZeneca
AstraZeneca Just Massively One-Upped Pfizer. Here’s What It Means for the Stock
As two of the world’s largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca (NASDAQ: AZN) both have grand visions for how to grow even larger over the coming years. And with billions of dollars devoted to research and development, it’s almost certain to lead to the discovery of new golden-goose medicines that should […]
Pfizer wins cancer drug patent case against AstraZeneca
The US District Court for the District of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer in damages for infringing patents related to the lung cancer drug Tagrisso. The patents in question are licensed by Pfizer to Puma Biotechnology for the production of the breast cancer drug Nerlynx, Reuters has reported. The jury found […]
AstraZeneca to withdraw COVID vaccine globally as demand dips
(Reuters) -AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines” since the pandemic. The company also said it would proceed to withdraw the vaccine Vaxzevria’s marketing authorizations within Europe. “As multiple, variant COVID-19 vaccines have since been developed there is a surplus […]
AstraZeneca withdraws its COVID-19 vaccine from global market
AstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker said Wednesday. The shot, which was never authorized in the U.S., was widely used across the world in the early part of the global vaccine drive. AstraZeneca’s shot was cheaper to make and easier to distribute than the mRNA shots […]
AstraZeneca withdraws Covid jab from market due to plummeting demand
The Covid-19 vaccine developed by pharmaceutical giant AstraZeneca during the pandemic has been withdrawn from the market. The company said it was “incredibly proud” of the vaccine, but that it had been withdrawn due to plummeting demand. Vaccine makers agreed that it could be manufactured on a “not-for-profit basis for the duration of the pandemic […]
AstraZeneca withdraws Covid vaccine as demand dives
Anglo-Swedish drugmaker AstraZeneca on Wednesday said it was withdrawing Covid vaccine Vaxzevria, one of the first produced in the deadly pandemic, citing “commercial reasons” following a slump in demand. “As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines. This has led to a decline in demand for […]
Families of people who died after Covid vaccination abandon attempt to sue AstraZeneca
Families whose loved ones died after taking the AstraZeneca Covid vaccine have abandoned attempts to sue the pharmaceutical giant after being told that they were likely to lose. Gareth Eve and other families whose relatives were harmed after having the jab have pulled out of the High Court case after being told that they would be […]
AstraZeneca admits for first time its Covid vaccine can cause rare side effect
AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause a rare side effect, in an apparent about-turn that could pave the way for a multi-million pound legal payout. The pharmaceutical giant is being sued in a class action over claims its vaccine, developed with the University of Oxford, […]
AstraZeneca Bolsters Cell Therapy Pipeline With Over $1B Deal For China-Based Gracell Biotechnologies
AstraZeneca Plc (NASDAQ: AZN) has agreed to acquire Gracell Biotechnologies Inc (NASDAQ: GRCL), further strengthening AstraZeneca’s cell therapy portfolio. The deal value is $2.00/share (equivalent to $10/ADS ADS of Gracell) plus a non-tradable contingent value right of $0.30/share (equivalent to $1.50/ADS of Gracell) in cash. The proposed acquisition will enrich AstraZeneca’s growing pipeline of cell therapies with GC012F, a […]